Assessment of Breast Cancer-Related Arm Lymphedema
Kľúčové slová
Abstrakt
Termíny
Naposledy overené: | 05/31/2019 |
Prvý príspevok: | 01/22/2019 |
Odhadovaná registrácia bola odoslaná: | 06/04/2019 |
Prvý príspevok: | 06/06/2019 |
Posledná aktualizácia bola odoslaná: | 06/08/2019 |
Posledná aktualizácia bola zverejnená: | 06/10/2019 |
Aktuálny dátum začatia štúdie: | 05/31/2019 |
Odhadovaný dátum dokončenia primárneho okruhu: | 12/31/2021 |
Odhadovaný dátum dokončenia štúdie: | 12/31/2021 |
Stav alebo choroba
Intervencia / liečba
Diagnostic Test: patients with lymphedema
Fáza
Skupiny zbraní
Arm | Intervencia / liečba |
---|---|
patients with lymphedema | Diagnostic Test: patients with lymphedema ways to examine lymphedema |
Kritériá oprávnenosti
Pohlavia vhodné na štúdium | Female |
Metóda vzorkovania | Non-Probability Sample |
Prijíma zdravých dobrovoľníkov | Áno |
Kritériá | Inclusion Criteria: - Patients with breast cancer who underwent axillary, axillary and other axillary surgery. - Patients who have complaints about upper extremity edema and are willing to undergo examination. - Sign the informed consent. Exclusion Criteria: - Bilateral breast cancer. - A history of allergy to contrast agents. - There are arteriovenous thrombosis in the affected limb. - Regional lymph node recurrence - Did not sign informed consent. - Serious heart, brain and other diseases. - The primary lymphatic system diseases (such as lymphatic leakage). - Only one side of the limb received ICG angiography. |
Výsledok
Primárne výstupné opatrenia
1. Sensitivity and specificity of indocyanine green (ICG) lymphography [From date of enrollment until the date of first documented lymphedema, assessed up to 2 years.]